Clinical Trial Update: Effects of Early Short-term Intravenous Iron Supplements Combined EPO in Preterm Infants [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing early short-term intravenous iron supplements combined with erythropoietin in preterm infants for malnutrition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malnutrition in Preterm Infants

Drugs mentioned

• erythropoietin (EPO) (erythropoietin)
• intravenous iron supplements

Snippet

Sponsor: Kunshan First People's Hospital Affiliated to Jiangsu University | Conditions: Malnutrition | Phase 4 | Status: COMPLETED